Search
Jean-Luc Herbeaux to become Hovione CEO
Hovione today announced the appointment of Dr. Jean-Luc Herbeaux as Hovione’s Chief Executive Officer, effective 1st April 2022
Hovione strengthens its global position as a top employer for the third consecutive year
Hovione has once again solidified its position as a top employer.
Hovione Announces Partnership to Support Manufacturing of Antiviral Veklury® for COVID-19
Hovione today announced the signing of a partnership agreement with Ligand to significantly ramp up the production output of Captisol®
Sunriser® DPI
High Performance, High-Dose Capsule DPI.
Continuous Flow
Expand the established chemistry space with Continuous Flow to deliver robust and sustainable processes.
How the drug services industry found itself prepared for a pandemic
C&EN, 26 September 2021
Hovione is recognized as a Top Employer 2023
This certification is a recognition of Hovione´s resolve to put people first, and a validation that the investment in HR excellence is delivering.
Hovione and GEA Strengthen Partnership to Advance Continuous Tableting Technology
The agreement furthers Hovione´s ability to bring the benefits of continuous tableting, including reduced time to market and increased supply chain flexibility, to pharmaceutical customers globally